ProMetic Life Sciences Inc. (PFSCF: OTCQX International) | Prometic announces the publication of PBI-4050’s antifibrotic activity in liver diseases in Journal of Pharmacology and Experimental Therapeutics

OTC Markets Group – News, Filings & Corporate Actions

Pin It